Search research articles
Contact Us
Filters
Showing results (111-120 of 199) with videos related to
Page
of 20
Sort By:
Blood
|
May 24, 2003
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation
Ginna G Laport, Bruce L Levine, Edward A Stadtmauer, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 20, 2022
Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory Setting
Sunita D Nasta, Mitchell E Hughes, Esin C Namoglu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 12, 2010
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
David L Porter, Edwin P Alyea, Joseph H Antin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 2, 2014
Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201
Edmund K Waller, Brent R Logan, Wayne A C Harris, et al.
Blood Advances
|
December 12, 2022
Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome
Shakthi T Bhaskar, Vivek G Patel, David L Porter, et al.
Clinical Transplantation
|
September 9, 2005
Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder
Donald E Tsai, Nicole A Aqui, John E Tomaszewski, et al.
Future Oncology (London, England)
|
May 18, 2022
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma
Daanish Hoda, Robert Richards, Edward A Faber, et al.
The New England Journal of Medicine
|
July 13, 2012
Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease
Ran Reshef, Selina M Luger, Elizabeth O Hexner, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
February 22, 2022
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant
Rachel V Hatch, Craig W Freyer, Alison Carulli, et al.
American Journal of Hematology
|
August 19, 2007
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support
Dan T Vogl, Stephen V Liu, Elise A Chong, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 199) with videos related to
Sort By:
Page
of 20
Blood
|
May 24, 2003
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation
Ginna G Laport, Bruce L Levine, Edward A Stadtmauer, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 20, 2022
Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory Setting
Sunita D Nasta, Mitchell E Hughes, Esin C Namoglu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 12, 2010
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
David L Porter, Edwin P Alyea, Joseph H Antin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 2, 2014
Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201
Edmund K Waller, Brent R Logan, Wayne A C Harris, et al.
Blood Advances
|
December 12, 2022
Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome
Shakthi T Bhaskar, Vivek G Patel, David L Porter, et al.
Clinical Transplantation
|
September 9, 2005
Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder
Donald E Tsai, Nicole A Aqui, John E Tomaszewski, et al.
Future Oncology (London, England)
|
May 18, 2022
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma
Daanish Hoda, Robert Richards, Edward A Faber, et al.
The New England Journal of Medicine
|
July 13, 2012
Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease
Ran Reshef, Selina M Luger, Elizabeth O Hexner, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
February 22, 2022
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant
Rachel V Hatch, Craig W Freyer, Alison Carulli, et al.
American Journal of Hematology
|
August 19, 2007
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support
Dan T Vogl, Stephen V Liu, Elise A Chong, et al.
Page
of 20